Target intelligence / Profile preview

Dopamine receptor D1, Dopamine receptor D3, Dopamine receptor D4 (DRD1, DRD3, DRD4)

Target
DRD1, DRD3, DRD4
Molecular classification
G protein-coupled receptor (GPCR), Receptor
01

Overview

Dopamine receptor D1, D3, and D4 are three members of the dopamine receptor family within the G protein-coupled receptor superfamily. D1 is part of the D1-like group, coupled to Gs proteins and generally stimulates cAMP production; D3 and D4 are in the D2-like group, coupled to Gi/o proteins and inhibit cAMP signaling[1][2][3][5][6]. These receptors are differentially localized in the brain: D1 is widely expressed throughout the CNS, D3 and D4 show more selective expression patterns, especially D4 in the prefrontal cortex and hippocampus[4][5]. They play key roles in neurophysiology, including regulation of motor activity, reward, cognition, and emotion. Dysfunction or altered signaling of these receptors is implicated in several neurological and psychiatric conditions, and they are important therapeutic targets for drugs treating disorders such as schizophrenia, Parkinson’s disease, and attention deficit disorders[1][2][4][5][6].

Other names
D1 receptorD-1 receptorDA D1 receptorD3 receptorD-3 receptorDA D3 receptorD4 receptorD-4 receptorDA D4 receptor
02

Mechanism of action

Antagonism (blockade) or agonism (stimulation) of dopamine receptors to modulate downstream G protein signaling (Gs for D1, Gi/o for D3, D4) Regulation of cAMP levels via G protein coupling (D1 increases cAMP, D3/D4 decrease cAMP)

03

Biological functions

Signal transductionRegulation of neurotransmissionModulation of motor control, cognition, mood, attention, and emotion
04

Disease associations

Neurodegenerative disease (e.g., Parkinson's disease)Psychiatric/neuropsychiatric disorders (e.g., schizophrenia, mood disorders, attention-deficit hyperactivity disorder, substance use disorders, Tourette's syndrome)
05

Safety considerations

Neurological side effects due to involvement in motor function and cognition (e.g., extrapyramidal symptoms for D2-like antagonist drugs)Cardiovascular effects (some dopaminergic drugs)Pro-cognitive and abuse potential depending on drug class
06

Interacting drugs

Antipsychotics (haloperidol, risperidone, nemonapride, eticlopride—many are nonselective)

4 more in the full profile.

07

Biomarkers

None established as routine clinical biomarkers for patient selection or efficacy, though receptor imaging and expression may support research or diagnosis in neurological and psychiatric disease

Beyond the preview

Go deeper on Dopamine receptor D1, Dopamine receptor D3, Dopamine receptor D4 (DRD1, DRD3, DRD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine receptor D1, Dopamine receptor D3, Dopamine receptor D4 (DRD1, DRD3, DRD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call